XML 55 R39.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Investments in Other Entities and Noncontrolling Interest in a Subsidiary (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2024
Schedule of Equity Method Investments [Line Items] |
Summary of financial information |
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Year Ended December 31,
​ | ​ | 2022 | ​ | 2023 | ​ | 2024
Revenue | ​ | $ | 1,217 | ​ | $ | 615 | ​ | $ | 574
Gross profit | ​ | ​ | 506 | ​ | ​ | 327 | ​ | ​ | 287
Operating loss | ​ | ​ | (2,556) | ​ | ​ | (4,513) | ​ | ​ | (9,150)
Net loss | ​ | $ | (2,585) | ​ | $ | (4,539) | ​ | $ | (9,173)
​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | As of December 31,
​ | ​ | 2023 | ​ | 2024
Current assets | ​ | $ | 1,436 | ​ | $ | 1,445
Non-current assets | ​ |  | 4,281 | ​ |  | 811
Total assets | ​ | $ | 5,717 | ​ | $ | 2,256
​ | ​ | ​ | ​ | ​ | ​ | ​
Current liabilities | ​ | $ | 1,231 | ​ | $ | 232
Non-current liabilities | ​ |  | 6,312 | ​ |  | 13,023
Total liabilities | ​ | $ | 7,543 | ​ | $ | 13,255
TotalEnergies |
Schedule of Equity Method Investments [Line Items] |
Summary of financial information | The following table presents the combined summarized financial information of the TotalEnergies joint venture (in thousands):
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Year Ended December 31,
​ | ​ | 2022 | ​ | 2023 | ​ | 2024
Revenue | ​ | $ | — | ​ | $ | 1,462 | ​ | $ | 4,489
Gross profit | ​ | ​ | — | ​ | ​ | 173 | ​ | ​ | 2,540
Operating loss | ​ | ​ | (454) | ​ | ​ | (3,414) | ​ | ​ | (1,363)
Net loss | ​ | $ | (454) | ​ | $ | (4,951) | ​ | $ | (3,372)
​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | As of December 31,
​ | ​ | 2023 | ​ | 2024
Current assets | ​ | $ | 13,838 | ​ | $ | 2,268
Non-current assets | ​ |  | 33,289 | ​ |  | 32,200
Total assets | ​ | $ | 47,127 | ​ | $ | 34,468
​ | ​ | ​ | ​ | ​ | ​ | ​
Current liabilities | ​ | $ | 2,518 | ​ | $ | 2,315
Non-current liabilities | ​ |  | 29,595 | ​ |  | 20,511
Total liabilities | ​ | $ | 32,113 | ​ | $ | 22,826
bpJV |
Schedule of Equity Method Investments [Line Items] |
Summary of financial information |
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Year Ended December 31,
​ | ​ | 2022 | ​ | 2023 | ​ | 2024
Revenue | ​ | $ | — | ​ | $ | — | ​ | $ | 6,129
Gross profit | ​ | ​ | — | ​ | ​ | — | ​ | ​ | (6,507)
Operating loss | ​ | ​ | (7,210) | ​ | ​ | (15,074) | ​ | ​ | (40,165)
Net loss | ​ | ​ | (5,485) | ​ | ​ | (10,241) | ​ | ​ | (32,268)
Net loss attributable to bpJV | ​ | $ | (5,426) | ​ | $ | (9,127) | ​ | $ | (27,669)
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ | ​ | As of December 31,
​ | ​ | ​ | ​ | 2023 | ​ | 2024
Current assets |  | ​ | ​ | ​ | $ | 209,973 | ​ | $ | 142,505
Non-current assets | ​ | ​ | ​ | ​ | ​ | 296,240 | ​ | ​ | 351,016
Total assets | ​ | ​ | ​ | ​ | $ | 506,213 | ​ | $ | 493,521
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Current liabilities | ​ | ​ | ​ | ​ | $ | 27,706 | ​ | $ | 19,132
Non-current liabilities | ​ | ​ | ​ | ​ | ​ | 13,558 | ​ | ​ | 41,708
Total liabilities | ​ | ​ | ​ | ​ | $ | 41,264 | ​ | $ | 60,840
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Equity attributable to shareowners of bpJV | ​ | ​ | ​ | ​ | $ | 440,613 | ​ | $ | 412,944
Equity attributable to noncontrolling interest | ​ | ​ | ​ | ​ | ​ | 24,336 | ​ | ​ | 19,737
Total equity | ​ | ​ | ​ | ​ | $ | 464,949 | ​ | $ | 432,681
SAFE S.p.A. |
Schedule of Equity Method Investments [Line Items] |
Summary of financial information |
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Year Ended December 31,
​ | ​ | 2022 | ​ | 2023 | ​ | 2024
Revenue | ​ | $ | 110,104 | ​ | $ | 97,740 | ​ | $ | 89,345
Gross profit | ​ | ​ | 24,902 | ​ | ​ | 24,098 | ​ | ​ | 26,557
Operating income (loss) | ​ | ​ | 2,513 | ​ | ​ | (562) | ​ | ​ | (2,714)
Net income (loss) | ​ | $ | 951 | ​ | $ | (2,148) | ​ | $ | (3,791)
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ | ​ | ​ | As of December 31,
​ | ​ | ​ | ​ | ​ | 2023 | ​ | 2024
Current assets |  | ​ | ​ | ​ | $ | 79,981 | ​ | $ | 59,628
Non-current assets | ​ | ​ | ​ | ​ | ​ | 59,636 | ​ | ​ | 54,985
Total assets | ​ | ​ | ​ | ​ | $ | 139,617 | ​ | $ | 114,613
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Current liabilities | ​ | ​ | ​ | ​ | $ | 70,193 | ​ | $ | 58,410
Non-current liabilities | ​ | ​ | ​ | ​ | ​ | 20,888 | ​ | ​ | 14,667
Total liabilities | ​ | ​ | ​ | ​ | $ | 91,081 | ​ | $ | 73,077

X
- Definition Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3 + Details
Name: | us-gaap_EquityMethodInvestmentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 28 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (a)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3 + Details
Name: | us-gaap_ScheduleOfEquityMethodInvestmentsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=clne_TotalJvJointVentureAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=clne_BpJvJointVentureAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=clne_SFES.p.a.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |